Reported 2 days ago
Jim Cramer recently refrained from commenting on GoodRx Holdings, Inc. (NASDAQ:GDRX) during his show, echoing the advice of his grandmother that if you don't have anything good to say, don't say anything at all. GoodRx, which assists consumers in finding lower prescription drug prices, has seen its stock plummet over 82% since Cramer previously called it a 'no-go' option in 2022.
Source: YAHOO